Merz Aesthetics Inc. is an internationally active family-owned pharmaceutical company that develops and distributes advanced treatments for dermatology, neurology, and aesthetic medicine. With over a century of healthcare experience, Merz strives to enhance patients’ health, allowing them to live, feel, and look better. Merz Aesthetics products are well-known and well-loved by healthcare professionals and their clients in more than 90 countries.
Merz was established in 1908 in Frankfurt am Main, Germany by a pharmacist and chemist Friedrich Merz and is currently owned by the 4th generation of the Merz family. Brand is headquartered in Raleigh, NC, USA and has R&D facilities in 3 locations: Frankfurt, Raleigh, and Mesa. Since developing one of the first anti-wrinkle solutions in the world in 1953, Merz has been a driver for innovation and quality in the fast-growing world of aesthetic medicine.
Brand provides an extensive selection of minimally invasive and non-invasive skin rejuvenation treatments. Its unique and holistic product portfolio includes botulinum neurotoxin free of complexing proteins, a comprehensive line of dermal fillers, energy-based devices, and professional skincare products. Merz Aesthetics dermal fillers help to deliver natural-looking results that patients desire, for both face and body.
The Belotero range of hyaluronic acid dermal fillers is tailor-made to adapt to different facial areas and injection depths, indicated to be used for smoothing out wrinkles, restoring facial volumes, enhancing skin quality, and increasing lip volume. The Belotero series includes products of varying viscosity and elasticity.
Radiesse is the first and only FDA-approved CaHA filler range that offers your patients immediate and long-term improvement by promoting the body’s own natural collagen production. Once injected, it restores volume to help reduce moderate and severe wrinkles and facial folds, such as nasolabial folds and marionette lines.
Xeomin is a double-filtered smoothing injection that is administered into muscles for a temporary improvement in the appearance of moderate to severe frown lines between the eyebrows. The main component of Xeomin, botulinum toxin type A, inhibits muscular contraction by interacting with nerve endings in the muscles, ultimately softening the appearance of facial wrinkles.
In addition to investing around 100 million euros yearly in the development of new healthcare products, formulations, and technologies, employs more than 300 people globally who work on innovation and R&D projects. Merz Aesthetics has developed into a global leader in the field of aesthetic medicine thanks to its dedication to innovation and strategic pursuit of breakthrough solutions and technologies.
